Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-03-24
2000-10-17
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514339, 546201, 5462734, A61K 31445, C07D40104
Patent
active
061332879
ABSTRACT:
Described herein are compounds with affinity for the 5-HT.sub.6 receptor, which have the general formula: wherein:
REFERENCES:
patent: 3481953 (1969-12-01), Herbst et al.
patent: 3489429 (1970-01-01), Herbst et al.
patent: 3489770 (1970-01-01), Herbst et al.
patent: 4021431 (1977-05-01), Zenitz
patent: 4870085 (1989-09-01), Glaser et al.
patent: 5066660 (1991-11-01), Oxford et al.
patent: 5834493 (1998-11-01), Gil-Guintero et al.
patent: 5846982 (1998-12-01), Audia et al.
Scholl et al. "Selective serotonin reuptake nhibitors in treatment of . . . " Medline 95098179, 1995.
Amlaiky et al. "The mouse HT5 and 5HT6 receptors . . . " Biosis 87634, 1993.
Whitaker-Azmitia et al. "The neuropharmacology of serotonin" N. Y. Aca. Sci. v. 600, p. 168, 1990.
Taylor et al. Molecular determinants for recognition of RU 24969 nanlogs . . . ) Mol. Pharm. v.34, pp. 42-53, 1988.
Hansch et al. "The structure-activity relationship of inhibitors of serotonin uptake . . . " J. Computor aided mol. design. vol. 5, pp. 441-453, 1991.
Bundgaard "Design of prodrugs" Elsevier, p. 28-29, 1986.
Guillaume et al. "Synthesis of 3-(1,2,3,6-tetrhydropyridin-4-yl)!Hindoles and study . . . " CA 107:70255, 1987.
Simpson et al. "Autoradiography with [3H]8-OH-DPAT reveals increases in 5HT1A . . . " CA 125:354432, 1996.
International Application No. WO 90/05721 published May 31, 1990.
International Application No. WO 92/13856 published Aug. 20, 1992.
International Application No. WO 95/32966 published Dec. 7, 1995.
International Application No. WO 96/25397 published Aug. 22, 1996.
International Application No. WO 97/47302 published Dec. 18, 1997.
Taylor et al., Molecular Pharmacology, vol. 34, 1988, pp. 42-53, "Molecular Determinants for Recogination of RU 24969 Analogs at Central 5-Hydroxytryptamine . . . ".
Zheng et al., Heterocycles, vol. 37, No. 3, 1994, "Vinylation of the indole 3-postion via palladium-catalyzed cross-coupling".
Zheng et al., Tetrahedron Letters, vol. 34, No. 14, pp. 2235-2238, 1993, "Palladium Catalyzed Cross-Coupling Reaction between 3-Indole Boronic Acids . . . ".
Japanese Abstract No. JP 05043544, Feb. 23, 1993.
Edwards Louise
O'Brien Anne
Slassi Abdelmalik
Tehim Ashok
Xin Tao
Allelix Biopharmaceuticals Inc.
Chang Ceila
LandOfFree
Piperidine-indole compounds having 5-HT.sub.6 affinity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperidine-indole compounds having 5-HT.sub.6 affinity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine-indole compounds having 5-HT.sub.6 affinity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-469337